Unexpected cardiotoxicity in haematological bortezomib treated patients

被引：155
|
作者：
Orciuolo, Enrico [1 ]
Buda, Gabriele
Cecconi, Nadia
Galimberti, Sara
Versari, Daniele
Cervetti, Giulia
Salvetti, Antonio
Petrini, Mario
机构：
[1] Univ Pisa, Dept Oncol Transplant & Adv Med, Sect Haematol, I-56100 Pisa, Italy
[2] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 138卷 / 03期
关键词：
bortezomib; cardiotoxicity; haematological patients;
D O I：
10.1111/j.1365-2141.2007.06659.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：396 / 397
页数：2
相关论文
共 50 条
  • [31] Hyponatremia Is Not a Rare Adverse Event in Bortezomib-Treated Patients
    Paydas, Semra
    CHEMOTHERAPY, 2011, 57 (05) : 434 - 436
  • [32] Publication: Unexpected Cardiotoxicity in Patients WithHER2-Mutant NSCLC Treated WithTrastuzumab Deruxtecan: A Case Report (vol 3, 100432, 2022)
    Planchard, David
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (09):
  • [33] Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
    Castro, T. B. M.
    Hallack Neto, A. E.
    Atalla, A.
    Ribeiro, L. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2016, 49 (06) : e5128
  • [34] Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib
    Robak, Pawel
    Weglowska, Edyta
    Drozdz, Izabela
    Mikulski, Damian
    Jarych, Dariusz
    Ferlinska, Magdalena
    Wawrzyniak, Ewa
    Misiewicz, Malgorzata
    Smolewski, Piotr
    Fendler, Wojciech
    Szemraj, Janusz
    Robak, Tadeusz
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [35] DETECTION OF BIOLOGICAL RELAPSE IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH BORTEZOMIB
    Murillo Florez, I
    Andrade Campos, M.
    Colorado Ledesma, E.
    Espinosa, L. N.
    Tercero, M. M.
    Rupay Rojas, R.
    Giraldo, P.
    HAEMATOLOGICA, 2015, 100 : 114 - 114
  • [36] Bortezomib neuropathy in patients treated for multiple myeloma: A multicenter experience
    Siniscalchi, A.
    Falco, P.
    Spagnoli, A.
    Palumbo, A.
    Rizzo, M.
    de Fabritiis, P.
    Amadori, S.
    Caravita, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 143 - 143
  • [37] Immune-mediated neuropathies in myeloma patients treated with bortezomib
    Ravaglia, Sabrina
    Corso, Alessandro
    Piccolo, Giovanni
    Lozza, Alessandro
    Alfonsi, Enrico
    Mangiacavalli, Silvia
    Varettoni, Marzia
    Zappasodi, Patrizia
    Moglia, Arrigo
    Lazzarino, Mario
    Costa, Alfredo
    CLINICAL NEUROPHYSIOLOGY, 2008, 119 (11) : 2507 - 2512
  • [38] Acyclovir to prevent herpes zoster in myeloma patients treated with bortezomib
    Vickrey, Eric
    Fellingham, Sharon
    Mehta, Jayesh
    Singhal, Seema
    BLOOD, 2007, 110 (11) : 275B - 275B
  • [39] Neuropathy in multiple myeloma patients treated with bortezomib: A multicenter experience
    Caravita, Tommaso
    Petrucci, Maria Teresa
    Spagnoli, Alessandra
    Siniscalchi, Agostina
    Offidani, Massimo
    Federico, Vincenzo
    Falco, Patrizia
    Rizzo, Manuela
    Palumbo, Antonio
    de Fabritiis, Paolo
    BLOOD, 2007, 110 (11) : 280B - 280B
  • [40] Bortezomib-associated polyradiculoneuritis in patients treated for multiple myeloma
    Raynouard, I.
    Gendreau, S.
    Viala, K.
    Maisonobe, T.
    Hoang-Xuan, K.
    Psimaras, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 672 - 672
12345